Clinical Trials Browser

Unknown × Lymphoma, T-Cell × pembrolizumab × Clear all

NCT03021057 2019-04-17

Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell